US Cardiac Biomarker Market: Industry Growth, Market Size, Share and Forecast 2019-2025

1. Orion Market Research US Cardiac Biomarker Market: Industry Growth, Market Size, Share and Forecast 2019-2025 For free sample request visit: https://www.omr.com/request- sample/us-cardiac-biomarker-market Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

2. US Cardiac Biomarker Market: Industry Growth, Market Size, Share and Forecast 2019-2025 The US Cardiac Biomarker Market is estimated to grow significantly at a CAGR of 7.2% during the forecast period. The major factors that propel the market growth include the high prevalence of CVDs and heart related diseases in the country coupled with robust healthcare expenditure. According to the CDC about half of the people who develop heart failure die within 5 years of diagnosis. Heart failure costs the nation an estimated $30.7 billion each year. This total includes the cost of healthcare services, medications to treat heart failure, and missed days of work. High healthcare expenditure in the US enabling the growth of the market. To learn more about this report request a free sample copy @ https://www.omr.com/request-sample/us- cardiac-biomarker-market According to the Centre for Disease Control & Prevention (CDC), the US national healthcare expenditure was around $3.3 trillion in 2016. The US has the highest healthcare spending across the globe. In the US per capita, healthcare expenditure is around $10,348 per person, in 2016. The high healthcare expenditure raises the demand for advanced diagnosis technologies such as cardiac biomarkers that further peoples the market growth in the country. The market is segmented on the basis of type, application, and location of testing. Based on type, the market is segregated into Creatine kinase (CK-MB), Troponins (T, I), Myoglobin, Natriuretic peptides (BNP & NT- PROBNP), Ischemia modified albumin and Others. The troponin is anticipated to be the fastest growing and has a considerable market share in the US cardiac biomarker market due to easy and high sensitivity that results in the high adoption of the test. Based on Application, the market is segmented into myocardial infraction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. On the basis of the location of testing, the market is classified into laboratory testing and point of care testing.

3. A full report of US Cardiac Biomarker Market is available at: https://www.omrglobal.com/industry- reports/us-cardiac-biomarker-market US Cardiac Biomarker Market-Segmentation By Type Creatine kinase (CK-MB) Troponins(T,I) Myoglobin Natriuretic peptides (BNP & NT-PROBNP) Ischemia modified albumin Others By Application Myocardial infraction Congestive heart failure Acute coronary syndrome Atherosclerosis Others By Location of Testing Laboratory testing Point of care testing Company Profiles Abbott Laboratories Becton, Dickinson and Co. Bio-Rad Laboratories, Inc. Creative Diagnosis Critical Diagnostics Danaher Corp. LifeSign LLC Meso Scale Diagnostics LLC Myriad RBM Thermo Fisher Scientific Inc. For more customized data, request for report customization @ https://www.omr.com/report- customization/us-cardiac-biomarker-market About us:

4. Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. Media Contact: Company Name: Orion Market Reports Contact Person: Mr. Anurag Tiwari Email: info@orionmarketreports.com Contact no: +1 646-755-7667, +91 780-304-0404